Join to View Full Profile
165 Cambridge StSte 820Boston, MA 02114
Phone+1 855-644-6387
Fax+1 617-726-2019
Dr. Guidon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Duke University HospitalFellowship, Neuromuscular Medicine (Neurology), 2012 - 2013
- Duke University HospitalFellowship, Neuromuscular Medicine (Neurology), 2011 - 2012
- Duke University HospitalResidency, Neurology, 2008 - 2011
- Duke University HospitalInternship, Internal Medicine, 2007 - 2008
- University of Rochester School of Medicine and DentistryClass of 2007
Certifications & Licensure
- ME State Medical License Current
- MA State Medical License 2013 - 2025
- NC State Medical License 2007 - 2014
- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Neuromuscular Medicine
- American Board of Electrodiagnostic Medicine (ABEM)
Publications & Presentations
PubMed
- Consensus disease definitions for ophthalmic immune-related adverse events of immune checkpoint inhibitors.Eileen L Chang, Renee Liu, Kiandokht Keyhanian, Katie Huynh, Meghan Berkenstock
Journal for Immunotherapy of Cancer. 2025-04-08 - Trends and Disparities in the Utilization of Thymectomy for Myasthenia Gravis in the United States.Jennifer Morganroth, Leah Zuroff, Amanda C Guidon, Grant T Liu, Shawn J Bird
Neurology. Clinical Practice. 2024-10-01 - 6 citationsPeripheral nervous system immune-related adverse events due to checkpoint inhibition.Meabh O'Hare, Amanda C Guidon
Nature Reviews. Neurology. 2024-09-01
Press Mentions
- Myasthenia Gravis: Where Does Traditional Therapy Fit In?November 4th, 2024
- “Chemical Plasmapheresis” Drug for Myasthenia Gravis Is Safe, Lowers Antibodies, and Produces Hints of Efficacy in Phase 2 TrialJuly 11th, 2019
- Myasthenia Gravis: Framingham Resident Lives with Rare DiseaseJune 24th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: